Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa (Q80273839)

From Wikidata
Jump to navigation Jump to search
scientific article published on 04 May 2007
edit
Language Label Description Also known as
English
Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa
scientific article published on 04 May 2007

    Statements

    title
    Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    17483124
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17483124%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    30 December 2019
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q80273839&oldid=2272210071"